Adenocarcinoma of the rat esohagus in the presence of a proton pump inhibitor: A pilot study

Diseases of the Esophagus

Volumn 14, Issue 1, 2001, Pages 17-22

  Moore, K H ^a   Barry, P ^a   Burn, J ^b   Falk, G ^c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Davies Campbell de Lambert Pathology   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

^d NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR; PROTON PUMP;

ADENOCARCINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; DUODENOGASTRIC REFLUX; DUODENOSTOMY; DYSPLASIA; ESOPHAGOSTOMY; ESOPHAGUS DISEASE; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; PAPILLOMATOSIS; PILOT STUDY; PRIORITY JOURNAL; RAT; TISSUE DIFFERENTIATION; TUMOR; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; ESOPHAGUS TUMOR; GASTROESOPHAGEAL REFLUX; PATHOLOGY; SPRAGUE DAWLEY RAT;

ADENOCARCINOMA; ANIMALS; DISEASE MODELS, ANIMAL; ESOPHAGEAL NEOPLASMS; ESOPHAGOSTOMY; GASTROESOPHAGEAL REFLUX; MALE; OMEPRAZOLE; PILOT PROJECTS; PROTON PUMPS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0034743110     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2050.2001.00145.x     Document Type: Article

References (99)

1. The description of columnar lined esophagus associated with esophageal reflux
2. The columnar-lined (Barrett's) esophagus
3. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease
4. Pathogenesis of columnar cell-lined (Barrett's) esophagus
5. Barrett's esophagus: Congenital or acquired?: An experimental study of esophageal mucosal regeneration in the dog
6. Barrett's esophagus, functional assessment, proposed pathogenesis and surgical therapy
7. Gastroesophageal reflux (GOR) in patients with esophagitis or a columnar lined (Barrett's) esophagus
8. Alkaline gastroesophageal reflux: Implications in the development of complications in Barrett's columnar lined lower esophagus
9. The pH profile of Barrett's esophagus
10. Implication of the duodenogastric reflux in the pathogenesis of Barrett's esophagus
11. Effect of bile salts and related compounds on isolated esophageal mucosa
12. Relative importance of biliary and pancreatic secretions in the genesis of esophagitis in rats
13. Alkaline esophagitis: A comparison of the components of gastroduodenal contents to injure the rabbit esophagus
14. Adenocarcinoma complicating columnar epithelium-lined Barrett's esophagus
15. Endoscopic biopsy can detect high grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognisable neoplastic lesions
16. Surgical therapy in Barrett's esophagus
17. Adenocarcinoma in Barrett's esophagus. A clinicopathological study of 65 cases
18. Chronic peptic ulcer of the esophagus and 'esophagitis'
19. Columnar lined lower esophagus: An acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with twelve adenocarcinomas
20. Barrett's esophagus: Comparison of benign and malignant cases
21. Barrett's esophagus: Development of dysplasia and adenocarcinoma
22. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
23. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites
24. Incidence of cancer of the esophagus in the US by histological type
25. The increasing frequency of adenocarcinoma of the oesophagus
26. Increasing incidence of adenocarcinoma of the esophagus and the esophagogastric junction
27. Continuing climb in the rates of esophageal adenocarcinoma: An update
28. Prevalence of metaplasia at the gastro-esophageal junction
29. Increasing incidence of adenocarcinoma of the esophagus in both sexes within the Mersey region from 1963 to 1987
30. Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats
31. Influence of esophago-jejunostomy on the induction of adenocarcinoma of the distalesophagus in Sprague-Dawley rats by subcutaneous injection of 2,6 dimethylnitrosomorpholine
32. Sex and species differences in plasma gastrin and gastrin dependant variables. Studies in rats and mice during omeprazole treatment
33. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high dose ranitidine treatment
34. Nonparametric estimation from incoming observations
35. Efficiency of logistic regression and cox proportional hazards models in longitudinal studies
36. Biochemical and carcinogenesis studies on the rat esophagus: Effects of N-nitroso compounds and possible tumor promoting agents
37. The role of alkaline reflux in esophageal carcinogenesis induced by N-amyl-N-methylnitrosamine in rats
38. Influence of pancreatic and biliary reflux on the development of esophageal carcinoma
39. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: A putative model for carcinogenesis
40. Gastric carcinoma
41. Does duodenal juice reflux into the esophagus in complicated gastroesophageal reflux disease? Evaluation of a fiberoptic sensor for bilirubin
42. Operation-sequel-carcinoma - An experimental study
43. Induction of pancreatic tumors by longterm duodenogastric reflux
44. Duodenogastric reflux in rat carcinoma
45. The effect of bile on the induction of experimental intestinal tumors in rats
46. Effect of duodenogastric reflux on gastric mucosal proliferation after gastric surgery
47. Fecal bile acid profiles in patients with large bowel cancer in Japan
48. Upper gastrointestinal cancer in familial adenomatous polyposis
49. Relationship between duodenal bile salts and colorectal neoplasia
50. Barrett's esophagus and colonic tumors
51. Effect of duodenal juice of DNA index and cell proliferation in a model of esophageal carcinoma
52. Influence of pH on bile acid concentration in human, pig and commercial bile: Implications for alkaline gastroesophageal reflux
53. Pancreatic reflux produces intestinal metaplasia in experimental columnar lined esophagus
54. Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus
55. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's esophagus or Barrett's adenocarcinoma
56. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma
57. A human model of gastric carcinogenesis
58. Meta analysis of the risk of gastric stump cancer: Detection of high risk patient subsets for stomach cancer after remote partial gastrectomy for benign conditions
59. Increased risk of cancer at multiple sites after gastric surgery for peptic ulcer
60. Malignancy following surgery for benign peptic disease: A review
61. Mortality from and risk of gastric carcinoma among patients with pernicious anaemia
62. Pathogenesis of gastric cancer in anaemia
63. Carcinoma and intestinal metaplasia of the stomach in Columbian migrants
64. Risk factors of gastric precancerous lesions in a high risk Columbian population. II. Nitrate and nitrite
65. Determination of a non-volatile N-nitrosamine on a food matrix
66. Total nitroso compounds in gastric juice
67. Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach
68. Hyperplastic lesions of the gastrointestinal endocrine cells
69. Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation: Studies with omeprazole and ranitidine in intact and antrectomised rats
70. New aspects of the trophic action of gastrointestinal hormones
71. Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells
72. Trophic effects of gastrin on colorectal neoplasms in the rat
73. Effect of gastrin on tumor growth and cyclic nucleotide metabolism in xenotransplantable human gastric and colonic carcinomas in nude mice
74. Growth-promoting action of gastrin on human colonic and gastric tumor cells cultured in vitro
75. Effects of gastrointestinal hormones on the growth of human intestinal epithelial cells
76. Effects of gastrin, proglumide and somatostatin on growth of human colorectal cancer
77. Serum gastrin concentrations are higher in colorectal patients
78. Effect of hypergastrinaemia in chemical carcinogenesis of the esophagus in rats
79. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment
80. Postmarketing surveillance and the examination of the long term safety of anti ulcer drugs
81. Cancer occurrence in a cohort of patients treated with cimetidine
82. Histamine-2-receptor antagonists and gastric cancer risk
83. - on gastric acid secretion
84. Localisation of omeprazole and metabolites in the mouse
85. Acid suppression in duodenal ulcer: A metaanalysis to define optimal dosing with antisecretory drugs
86. Intragastric bacterial activity and nitrosation before, during and after treatment with omeprazole
87. Effect of oral omeprazole on serum gastrin and pepcinogen I levels
88. Effect of short-term and long-term feeding of omeprazole on rat gastric endocrine cells
89. Activation and hyperplasia of gastrin and enterochromaffin-like cells in the stomach
90. Toxicological studies on omeprazole
91. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion
92. Prevention of relapse of reflux esophagitis after endoscopic healing: Efficacy and safety of omeprazole compared with ranitidine
93. A review of the long term effects of acid inhibition in animals
94. Omeprazole in the long term management of patients with acid related diseases resistant to ranitidine
95. Efficacy and safety of long term omeprazole maintenance therapy in H2 blocker-resistant reflux esophagitis
96. Long term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: A prospective study
97. Clinical safety of omeprazole
98. Australian clinical trials of omeprazole in the management of reflux esophagitis
99. Omeprazole: Overview and opinion